RxDoctor Payments Data

Erika Grigg, MD

Gastroenterology · Kingsport, TNNPI 1487774410

Payments from drug & device makers

$6,111in general payments, 2019–2025

Across 421 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • AbbVie$1K
  • Johnson & Johnson$909
  • Takeda Pharmaceuticals U.S.A., Inc.$687
  • Ardelyx, Inc.$356
  • Gilead$167
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$6,03199%
  • Education$801%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,111 in reported general payments places this provider in the 60th percentile of 336 gastroenterology providers in Tennessee.

See all gastroenterology providers in Tennessee

Medicare billing

Part B allowed, 2024
$76,430
Medicare patients
287
Services billed
808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab23$320,606
Skyrizi On-BodyRisankizumab-Rzaa11$227,272
EntyvioVedolizumab14$115,263
CreonLipase/Protease/Amylase20$94,963
LinzessLinaclotide75$68,844
XifaxanRifaximin21$61,864
Mesalamine16$7,608
Lubiprostone31$7,418
Budesonide EcBudesonide13$6,120
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates87$5,606
MotegrityPrucalopride Succinate11$5,503
Esomeprazole Magnesium63$3,918
Famotidine156$2,847
Omeprazole155$2,543
SutabSod Sulf/Pot Chloride/Mag Sulf15$2,345

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,179$163,80795 claims
Takeda Pharmaceuticals U.S.A., Inc.Entyvio, Motegrity$687$120,76625 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$1,453$61,86421 claims
Braintree Laboratories, Inc.Sutab$16$2,34515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 336 gastroenterology providers in Tennessee.

Other gastroenterology in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →